282 related articles for article (PubMed ID: 33472522)
1. Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom.
Lorenzo-Vizcaya A; Isenberg D
Lupus; 2021 Apr; 30(5):702-706. PubMed ID: 33472522
[TBL] [Abstract][Full Text] [Related]
2. Good survival rates in systemic lupus erythematosus in southern Sweden, while the mortality rate remains increased compared with the population.
Ingvarsson RF; Landgren AJ; Bengtsson AA; Jönsen A
Lupus; 2019 Oct; 28(12):1488-1494. PubMed ID: 31551031
[TBL] [Abstract][Full Text] [Related]
3. Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls.
Bultink IEM; de Vries F; van Vollenhoven RF; Lalmohamed A
Rheumatology (Oxford); 2021 Jan; 60(1):207-216. PubMed ID: 32653901
[TBL] [Abstract][Full Text] [Related]
4. Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort.
Bartels CM; Buhr KA; Goldberg JW; Bell CL; Visekruna M; Nekkanti S; Greenlee RT
J Rheumatol; 2014 Apr; 41(4):680-7. PubMed ID: 24532834
[TBL] [Abstract][Full Text] [Related]
5. Comparative risks of cardiovascular disease events among SLE patients receiving immunosuppressive medications.
Choi MY; Li D; Feldman CH; Yoshida K; Guan H; Kim SC; Everett BM; Costenbader KH
Rheumatology (Oxford); 2021 Aug; 60(8):3789-3798. PubMed ID: 33369672
[TBL] [Abstract][Full Text] [Related]
6. Hospitalization in patients with systemic lupus erythematosus at Tawam Hospital, United Arab Emirates (UAE): Rates, causes, and factors associated with length of stay.
Aldarmaki R; Al Khogali HI; Al Dhanhani AM
Lupus; 2021 Apr; 30(5):845-851. PubMed ID: 33497303
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis of patients with systemic lupus erythematosus in a tertiary hospital in southern Brazil.
Hendler JV; de Souza L; de Freitas Zernow DC; Guimarães J; Bertotto T; Saldanha CF; Brenol JCT; Monticielo OA
Clin Rheumatol; 2017 Sep; 36(9):2005-2010. PubMed ID: 28653264
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine and Mortality Among Patients With Systemic Lupus Erythematosus in the General Population.
Jorge A; McCormick N; Lu N; Zheng Y; Esdaile J; De Vera M; Choi H; Aviña-Zubieta JA
Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1219-1223. PubMed ID: 32407570
[TBL] [Abstract][Full Text] [Related]
9. Mortality and causes of death among incident cases of systemic lupus erythematosus in Finland 2000-2008.
Elfving P; Puolakka K; Kautiainen H; Virta LJ; Pohjolainen T; Kaipiainen-Seppänen O
Lupus; 2014 Nov; 23(13):1430-4. PubMed ID: 25057036
[TBL] [Abstract][Full Text] [Related]
10. Do Death Certificates Underestimate the Burden of Rare Diseases? The Example of Systemic Lupus Erythematosus Mortality, Sweden, 2001-2013.
Falasinnu T; Rossides M; Chaichian Y; Simard JF
Public Health Rep; 2018; 133(4):481-488. PubMed ID: 29928843
[TBL] [Abstract][Full Text] [Related]
11. Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years.
Fei Y; Shi X; Gan F; Li X; Zhang W; Li M; Hou Y; Zhang X; Zhao Y; Zeng X; Zhang F
Clin Rheumatol; 2014 Jan; 33(1):57-63. PubMed ID: 24046218
[TBL] [Abstract][Full Text] [Related]
12. Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study.
de Luca Montes RA; Huq M; Godfrey T; Oon S; Calderone A; Kandane-Rathnayake R; Louthrenoo W; Luo SF; Jan Wu YJ; Golder V; Lateef A; Navarra SV; Zamora L; Hamijoyo L; Sockalingam S; An Y; Li Z; Katsumata Y; Harigai M; Chan M; Goldblatt F; O'Neill S; Lau CS; Cho J; Hoi A; Karyekar CS; Morand EF; Nikpour M
Adv Rheumatol; 2024 May; 64(1):38. PubMed ID: 38720354
[TBL] [Abstract][Full Text] [Related]
13. Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort.
Mok CC; Tse SM; Chan KL; Ho LY
Lupus; 2018 Apr; 27(5):722-727. PubMed ID: 29087260
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine may reduce risk of Pneumocystis pneumonia in lupus patients: a Nationwide, population-based case-control study.
Yeo KJ; Chen HH; Chen YM; Lin CH; Chen DY; Lai CM; Chao WC
BMC Infect Dis; 2020 Feb; 20(1):112. PubMed ID: 32041539
[TBL] [Abstract][Full Text] [Related]
15. Azathioprine and Mycophenolate Mofetil Adherence Patterns and Predictors Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.
Feldman CH; Collins J; Zhang Z; Xu C; Subramanian SV; Kawachi I; Solomon DH; Costenbader KH
Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1419-1424. PubMed ID: 30354025
[TBL] [Abstract][Full Text] [Related]
16. Mortality profile related to systemic lupus erythematosus: a multiple cause-of-death analysis.
Souza DC; Santo AH; Sato EI
J Rheumatol; 2012 Mar; 39(3):496-503. PubMed ID: 22247362
[TBL] [Abstract][Full Text] [Related]
17. Update οn the diagnosis and management of systemic lupus erythematosus.
Fanouriakis A; Tziolos N; Bertsias G; Boumpas DT
Ann Rheum Dis; 2021 Jan; 80(1):14-25. PubMed ID: 33051219
[TBL] [Abstract][Full Text] [Related]
18. Mortality and causes of death in systemic lupus erythematosus.
Trager J; Ward MM
Curr Opin Rheumatol; 2001 Sep; 13(5):345-51. PubMed ID: 11604587
[TBL] [Abstract][Full Text] [Related]
19. Optimizing the use of existing therapies in lupus.
Croyle L; Morand EF
Int J Rheum Dis; 2015 Feb; 18(2):129-37. PubMed ID: 25884457
[TBL] [Abstract][Full Text] [Related]
20. Mortality in patients with systemic lupus erythematosus in Colombia: a case series.
Aguirre-Valencia D; Suárez-Avellaneda A; Ocampo-Piraquive V; Posso-Osorio I; Naranjo-Escobar J; Nieto-Aristizábal I; Tobón GJ; Cañas CA
Clin Rheumatol; 2019 Jul; 38(7):1865-1871. PubMed ID: 30989407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
